Discover innovative new therapies against cancer and serious illnesses with unmet medical needs

Our unique, patient-centered innovation model

Thanks to its precision medicine platform, Oncodesign is able to orient at a very early stage its research and the development of innovative therapeutic solutions for resistant and unresponsive diseases

Investors

Word from the Chairman

Since our April 2014 IPO, we have accelerated our development and have become an international biopharma company specialized in precision medicine pursuing ambitious development objectives underpinned by acquisition-led growth and investments in innovative therapeutic research programs.